-4%
Calcitriol is indicated for the treatment and management of:
- Post-menopausal Osteoporosis
- Renal Osteodystrophy (particularly in dialysis patients)
- Post-surgical Hypoparathyroidism
- Idiopathic Hypoparathyroidism
- Pseudohypoparathyroidism
- Secondary Hyperparathyroidism in patients with moderate to severe chronic renal failure (pre-dialysis)
- Vitamin D-dependent Rickets

